About this trial
The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.
Eligibility criteria
Qualifiers
Patients aged 18-65.
Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies.
Received either ultrasound-guided corticosteroid injection or paraffin therapy.
Symptoms persisting for at least 3 months.
Disqualifiers
Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome).
History of previous injection or surgery for carpal tunnel syndrome.
Trial design
Treatments tested in this trial
- No intervention